Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How many years does kadcyla's market exclusivity last?Abbvie humira patent cliff navigation success?When oxcarbazepine patent expired?How does iron rich food intake impact lipitor's efficacy?How long have hydroxyzine pamoate been on the market?
See the DrugPatentWatch profile for Repatha
Repatha is the brand name for evolocumab, an injectable medicine used to lower low-density lipoprotein (LDL) cholesterol. It is made by Amgen.
Amgen is the company that markets Repatha. It is an established product in Amgen’s portfolio for cholesterol management.
Repatha is a prescription medicine used for people who need additional LDL-lowering beyond diet or who are at high cardiovascular risk, including certain patients with genetic lipid disorders and those with established cardiovascular disease.
Repatha competes in the PCSK9 inhibitor class of cholesterol-lowering drugs, including Praluent (alirocumab), also used to lower LDL cholesterol.
For the most accurate details on dosing, indications, prescribing information, and safety, the official source is Amgen’s product materials for Repatha. Sources: 1. https://www.amgen.com/our-medicines/repatha
Other Questions About Repatha :